INTRODUCTION
Transcatheter arterial chemoembolization (TACE) is utilized worldwide for the treatment of patients with unresectable hepatocellular carcinoma (HCC). Although various complications of TACE have been reported [1] , cerebral lipiodol embolism (CLE) after TACE is very rare. To our knowledge, 27 cases have been reported in the English literature, and possible pathways for carrying lipiodol from HCCs to systemic arteries have been hypo thesized [218] . This is the first report of CLE, in which the vascular lake phenomenon emerged during the TACE procedure and caused an intratumoral arteriovenous shunt, playing the most important role in its occurrence. We also discussed the mechanism of CLE and technical considerations to avoid this serious complication. We also provided a review of the literature.
CASE REPORT
A 63yearold man with a large recurrent HCC replacing most of the lateral segment of the liver and expanding to the left diaphragm was admitted to our hospital for a second TACE. He had a history of typeB cirrhosis for 3 years. Eight months prior to admission, he had undergone TACE for the same lesion via the left hepatic artery (LHA), and the postprocedural course was uneventful. Laboratory tests before second TACE revealed a serum total bilirubin level of 1.4 mg/dL, serum albumin level of 3.0 mg/dL, and prothrombin activity level of 81%. Neither ascites nor hepatic encephalopathy were found, which corresponded to ChildPugh class A. The αfetoprotein level was 900 ng/mL. At angiography, the large HCC was supplied by the LHA and the left inferior phrenic artery (LIPA) ( Figure 1A ) without an apparent arteriovenous (AV) shunt. For arterial redistribution to convert multiple feeding arteries into a single arterial supply, distal branches of the LIPA supplying HCC were embolized initially. To avoid migration of embolic materials into pulmonary vessels, the LIPA was embolized with 0.6 mL of a 33% mixture of nbutyl cyanoacrylate (Histoacryl; B. Braun, Melsungen, Germany) and lipiodol (Lipiodol; Terumo Corporation, Tokyo, Japan) ( Figure 1B ). Subsequently, we infused 140 mg of miriplatin (Miripla; Dainippon Sumitomo Pharma, Osaka, Japan) suspended in 7 mL of lipiodol via the LHA (Figure 2A ). This was followed by the injection of 1mmdiameter gelatin sponge particles (Gelpart; Nippon Kayaku Co. Ltd., Tokyo, Japan). However, the flow of the LHA did not slow down.
A repeated left hepatic angiography showed contrast material pooling associated with an aberrant intratumoral space newly developed during embolization, called the "vascular lake phenomenon" ( Figure 2B ). Latephase imaging revealed that the pericardiacophrenic vein was the draining vein ( Figure 2C ), which was not recognized at the time of the procedure but rather retrospectively after remasking and pixel shifting were performed. Epirubicin (10 mg) (Farmorubicin; Kyowa Hakko, Tokyo, Japan) emulsified in 9 mL of lipiodol was additionally infused into the LHA, followed by the injection of a 2mm block gelatin sponge (Spongel; Astellas, Tokyo, Japan) until the flow slowed down. Immediately after TACE, the patient became drowsy and disoriented. Unenhanced CT of the brain obtained 30 minutes after the procedure revealed multiple lesions of increased attenuation in the cerebral cortex, basal ganglia, thalami and cerebellum ( Figure 3 ). Simultaneously, a CT of the chest revealed hyperattenuation at both lung bases (Figure 4 ). The patient's oxygen saturation was 88%, indicating hypoxia. The patient was monitored in our intensive care unit on mechanical ventilator support. Echocardiography revealed no atrial septal defect or other intracardiac shunts. The patient's level of consciousness gradually improved, but his limb weakness persisted. He was discharged 8 wk later requiring the use of a wheelchair and assistance to eat meals.
DISCUSSION
TACE has been widely accepted as an effective therapy for HCC. Lipiodol is the most common embolic material used in TACE; it is usually mixed with anticancer drugs dissolved in nonionic contrast medium. Lipiodol can enter the microcirculation of the tumor and flow into the surrounding portal vein, which is the main drainage route from the hypervascular HCC [19] . However, lipiodol can reportedly flow into systemic circulation, causing pulmonary embolism and, rarely, cerebral embolism. We found 27 reports of CLE following TACE in 17 English studies (Table 1) . To reach the cerebral arteries, lipiodol must pass through two pathways, one from the tumor to the pulmonary artery (PA) and the other from the pulmonary artery to the left atrium (LA). Lipiodol accu mulation in the lung was identified simultaneously in 17 of 27 previously reported cases [24, 6, 810, 14, 16, 18] . Localized pooling of the contrast medium emerges occasionally during chemoembolization using drug eluting beads (DEBTACE), resembling extravasation within the tumor. This angiographic finding is known as the vascular lake phenomenon (VLP). As we reported herein, this phenomenon may also appear during chemo embolization using lipiodol, although it is difficult to distinguish a vascular lake from lipiodol accumulating in the tumor by fluoroscopy. Concerning the etiology of VLP during chemoembolization, Seki et al [20] speculated that rapid occlusion of most of the tumor vessels increased the pressure inside the fragile tumor microvasculature, causing disruption of the tumor architecture and a new blood space. VLP is thought to indicate a good local response in HCC patients undergoing DEBTACE [20, 21] . Nevertheless, the drainage routes from vascular lakes are unknown. To the best of our knowledge, this is the first report observing a vascular lake draining into systemic veins, resulting in an intratumoral AV shunt and affording lipiodol pathways to pulmonary vessels.
Intratumoral AV shunts can be the pathway to pul monary vessels [5, 7, 10] , and this was confirmed by angio graphy in only one CLE case [10] . On hepatic arteriography, the incidence of intratumoral AV shunts was reported to be 2.4% [22] . According to one study using technetium 99mlabeled macroaggregated albumin [23] , lung shunt fractions exceeding 10% were identified in 50 of 125 HCC patients (40%). The study also reported a direct correlation between angiographic tumor vascularity and lung shunt fractions [23] . The particles of lipiodol emulsion were less than 30 μm in size [24] , within the range of the size of technetium99mlabeled macroaggregated albumin (1060 μm in size). Lipiodol redistribution in the lungs may be more frequent than that previously thought.
TACE via IPA frequently results in pulmonary comp lications due to the existence of an AV shunt between the IPA and PA [25] . Some authors speculated that com munication between the IPA and pulmonary vessels via adhesive pleurae or tumor invasion is the most likely pathway from the tumor to the PA [4, 6] . In the present case, we performed IPA embolization using glue under DSA guidance, and the glue fragment never flowed into the pulmonary vessels.
In most previously reported cases of CLE, including the case described herein, a large dose of lipiodol was infused (Table 1 ). Cerebral and pulmonary lipiodol em bolisms have been reported in patients receiving more than 20 mL of iodized oil after TACE of HCC [4, 6, 16, 18] . According to Kishi et al [26] , when lipiodol was infused into the dog's hepatic artery, the amount of lipiodol oil deposition in the lungs was proportional to the lipiodol dose infused. They also found lipiodol deposits in the brain and pancreas [26] . These findings suggested a dose dependent circulation of oil droplets via hepatic sinusoids to pulmonary capillaries and then into the systemic circulation. It was suggested that the lipiodol dose should not exceed 1520 mL to prevent the risk of an extrahepatic embolism [4, 6] . Nevertheless, in 7 previous cases, CLE occurred when the lipiodol dose was < 15 mL [2, 5, 7, 14, 18] . The required lipiodol dose was determined by multiple factors, including the blood supply to the tumor, tumor size, catheter position and liver function reserve. When lipiodol goes through an intratumoral AV shunt, the dose of lipiodol required to accomplish HCC flow stasis increases. If there had not been an intratumoral AV shunt in the presented case, we could have accomplished flow stoppage with a lower dose of lipiodol.
CLE is thought to be associated with intrapulmo nary or intracardiac shunts [4, 7, 10, 16] . Evidence of an underlying intracardiac righttoleft shunt was proven by transesophageal echocardiogram in one previous case [7] ; however, the pathway from the PA to the LA was not verified in most previously reported cases of CLE, including the present case. Wu et al [9] speculated that an intrapulmonary arteriovenous shunt might appear during pulmonary lipiodol embolization due to increasing pulmonary artery pressure or hypoxia. Wu et al [10] added that communication between the systemic and pulmonary vessels might develop via adhesive pleurae or tumor invasion of the diaphragm, leading to a right toleft shunt. In a case report of delayed CLE, Wu et al [8] concluded that the rapid flow of the feeding artery washed out the lipiodol, and the lipiodol deposited in the lungs was washed out again upon entering the systemic circulation. Since it has been verified that fat globules < 7 μm in diameter can pass directly through the pulmonary arteriolar network [2] , lipiodol can enter the systemic circulation in the absence of a righttoleft shunt to cause cerebrovascular complications.
In summary, we presented a case in which a vas cular lake draining into systemic veins caused a lipiodol cerebral embolism. As intratumoral AV shunts via vas because the pathways from the PA to the LA cannot be blocked regardless of the mechanism by which they are developed.
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Case characteristics
A 63-year-old man with a large hepatocellular carcinoma underwent transcatheter arterial chemoembolization (TACE), but his level of consciousness deteriorated immediately after the procedure.
Clinical diagnosis
CT scan of the brain revealed multiple lesions of increased attenuation, and cerebral lipiodol embolism (CLE) was confirmed.
Differential diagnosis
There is no differential diagnosis.
Laboratory diagnosis
No specific finding was obtained by laboratory testing.
Imaging diagnosis
An angiography during TACE procedure revealed a newly developed vascular lake draining into systemic veins, which offered a pathway carrying lipiodol to pulmonary vessels and was the most likely cause of this serious complication.
Pathological diagnosis
No pathological examination was performed.
Treatment
The patient was treated in our intensive care unit.
Related reports
This is the first report of CLE, in which vascular lake phenomenon emerging during the procedure caused intratumoral arteriovenous shunt and played the most important role for its occurrence.
Term explanation
The term CLE describes cerebral lipiodol embolism.
Experiences and lessons
Arteriovenous shunt via vascular lake may develop during chemoembolization, repeated angiography during TACE procedures should be performed to prevent cular lakes may develop during chemoembolization, we recommend performing repeated angiography during TACE procedures, especially when obtaining a decreased blood flow is difficult. When an intratumoral AV shunt is identified by angiography, embolization of the feeding artery using coils or glue should be considered instead of an additional injection of lipiodol or embolic particles. We should try to prevent lipiodol accumulation in the lungs 
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